Skip to content

Alkermes ALKS Available For Sale Securities Debt Securities Current

Available For Sale Securities Debt Securities Current at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$912M+0.6%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
ALN
Alnylam PharmaceuticalsALNY
BridgeBio Pharma logo
BridgeBio PharmaBBIO
Royalty Pharma logo
Royalty PharmaRPRX

Segments

By geography

See full
IE$256.89M
US$203.63M

Other financials

Income statement

See full
Revenue$392.9M+28.2%
Gross profit$331.3M+28.8%
Operating income-$48.3M-450%
Net income-$66.5M-396%
EPS (diluted)-$0.40-408%

Balance sheet

See full
Cash & equivalents$351.6M-12.1%
Total debt$1.6B+2,034%
Total equity$1.8B+15.9%
Total assets$4.3B+105%

Cash flow

See full
Operating cash flow-$165.7M-268%
CapEx$4.1M-59.5%
Free cash flow-$169.8M-291%

Valuation

See full
Market cap$7.5B+9.7%
Enterprise value$8.73B+41.2%
P/E49.1×+29.7×
P/S4.8×+0.3×

Profitability

See full
Gross margin86.6%+2.2pp
Operating margin12.3%-13.6pp
Net margin9.8%-13.5pp
FCF margin14.2%-17.6pp

Returns & leverage

See full
Return on equity9.4%-16.1pp
Debt / equity0.9×+0.9×
Current ratio2.3×-1.1×

Where this comes from

Reported directly by Alkermes in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.

The official record: Alkermes’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alkermes's available for sale securities debt securities current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alkermes's available for sale securities debt securities current?
Alkermes (ALKS) reported available for sale securities debt securities current of $160.31M in Q1 2026.
How has Alkermes's available for sale securities debt securities current changed year-over-year?
Alkermes's available for sale securities debt securities current decreased by 66.9% year-over-year, from $484.21M to $160.31M.
What is the long-term trend for Alkermes's available for sale securities debt securities current?
Over 5 years (2020 to 2025), Alkermes's available for sale securities debt securities current has grown at a -11.2% compound annual growth rate (CAGR), from $362.07M to $199.65M.